Microarray scanners market to reach $1.5B by 2030

The Business Research Company says the global microarray scanners market is set to grow from $1 billion in 2025 to $1.5 billion by 2030, driven by genomics research, precision medicine and higher demand for high-throughput tools. North America led the market in 2025 as the report added fresh forecasting and analytics features in its 2026 edition.

Why it matters: - Microarray scanners sit at the center of gene expression, genomics and proteomics research. - Faster adoption of these tools can improve biomarker discovery, disease research and drug-development workflows. - Rising chronic disease prevalence is increasing demand for molecular research tools that can support diagnosis, prognosis and treatment planning.

What happened: - The Business Research Company published its Microarray Scanners Market Report 2026, covering market size, trends and global forecasts through 2035. - The market was valued at $1 billion in 2025 and is projected to reach $1.08 billion in 2026. - The report forecasts the market will rise to $1.5 billion by 2030. - North America was the largest regional market in 2025.

The details: - The report pegs 2025-2026 growth at a 8.1% compound annual growth rate. - It projects an 8.6% CAGR through 2030. - Historical growth is tied to expanding genomics research, higher funding for academic and scientific studies, wider microarray adoption, stronger demand for gene expression analysis and better fluorescence detection. - Forecast growth is linked to precision medicine research, biotechnology and pharmaceutical investment, large-scale genomic studies, AI-powered data analysis and demand for high-throughput equipment. - Anticipated trends include high-resolution fluorescence scanners, broader use in genomic and proteomic research, tighter software compatibility, more automated sample processing and multiplex detection. - Microarray scanners analyze arrays of DNA, RNA, proteins or other molecules fixed on glass slides or silicon chips. - The scanners measure fluorescent signals to show activity across thousands of genes. - The report says the market covers North America, Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report also adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.

Between the lines: - Chronic disease growth is one of the clearest demand drivers because it pushes more research into gene expression and biomarkers. - North America’s lead suggests research infrastructure and biotech spending still matter more than broad geographic reach for this category. - AI integration and automation point to a market shifting from basic scanning hardware toward more connected research workflows.

What's next: - The market is expected to keep growing as precision medicine, genomics and proteomics programs expand. - Higher-throughput systems and better analytics software are likely to shape buying decisions over the next several years. - The report’s added forecasting tools suggest vendors and investors are focusing more on segmentation and regional opportunity mapping.

The bottom line: - Microarray scanners remain a small but steadily expanding market, with growth powered by research spending, chronic disease needs and more advanced genomic analysis tools.